| abstract |
The present invention relates to all facets of novel polynucleotides, such as PR33a, PR33b, and PRB008, and their applications to research, diagnosis, forensics, and therapy. The polynucleotides are selectively expressed in prostate and therefore are useful in variety of ways, including, but not limited to, as molecular markers, as drug targets, and for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, or determining predisposition to diseases and conditions of the prostate. |